TITLE

Editor's Note

AUTHOR(S)
Paul, Reld
PUB. DATE
February 2009
SOURCE
Pharmaceutical Representative;Feb2009, Vol. 39 Issue 2, p3
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses various reports published within the issue, including one about the argument of Matt Wallach that the pharmaceutical representative position will have to change substantially in the near future and another one about the importance that pharmaceutical sales representatives should be more flexible, better trained and better integrated to the industry's operations.
ACCESSION #
36406402

 

Related Articles

  • THE SKY IS NO LIMIT. Ringler, Jennifer // Pharmaceutical Representative;Jun2011, Vol. 41 Issue 6, p18 

    The article explores the technology behind cloud computing which is becoming obligatory for pharmaceutical companies for competitive advantage in the U.S. It asserts that pharmaceutical industry still struggles in identifying the best and practicable means to leverage its potential in league...

  • Big changes for pharma companies may mean big changes in their CRM strategies. Bell, Lauren // DM News;5/18/2009, p7 

    The article focuses on the reports from Frost and Sullivans Ltd. regarding significance of customer relationship management (CRM) to the pharmaceutical industry. Matt Wallach, executive vice president (EVP) at Veeva Systems, attributed to downful of the billion dollar industry due to the...

  • Insider Insights.  // CenterWatch Weekly;1/13/2014, Vol. 18 Issue 2, p7 

    The article presents an interview with Matt Wallach, the co-founder and president of Veeva Systems. Wallach said that Veeva is focused on addressing the largest challenges in the life sciences industry. Wallach said that the industry has really gotten past concerns about cloud computing....

  • From Europe to China--a new focus. Wechsler, Jill // Pharmaceutical Executive;Sep97, Vol. 17 Issue 9, p20 

    Focuses on the pharmaceutical industry in the People's Republic of China. Signing of the Mutual Recognition Agreement on pharmaceutical plant inspection between the United States and Europe; Upgrading of domestic pharmaceutical capabilities in the country; Difficulty of drug distribution in the...

  • Ethics & enterprise--industry's dilemma. Schwartz, Harry // Pharmaceutical Executive;Nov97, Vol. 17 Issue 11, p24 

    Discusses the problems faced by the pharmaceutical industry in the United States involving ethical issues and standard practices. Collapse in the diet-drug demand due to its alleged adverse reaction; Lawsuit faced by SmithKline Beecham; Pediatric drugs not properly labeled and tested; Stiff...

  • Nigeria--strategy & strength for industry. Akanmu, Olu // Pharmaceutical Executive;Nov97, Vol. 17 Issue 11, p74 

    Focuses on the status and the restructuring trend of the pharmaceutical industry in Nigeria. Glaxo Wellcome's restructured business; Economic conditions of Nigeria; Government policies toward business; Presence of diverse pharmaceutical companies; Sale of over-the-counter drugs; Logistics and...

  • Information showcase.  // Pharmaceutical Executive;Nov97, Vol. 17 Issue 11, p85 

    Showcases products and services related to the pharmaceutical industry in the United States. Includes marketing support services; Book entitled `Contemporary Pharmacoeconomics'; Medical handbooks; Reporting services; Production services; Biotechnology support.

  • Homeopathic drugs naturally want spot in mainstream market. Magiera, Marcy; Colford, Steven W. // Advertising Age;8/31/92, Vol. 63 Issue 35, p3 

    Reports that marketers of homeopathic medicines want to write a prescription for the American mainstream and they are spending marketing dollars doing it. Remedies that treat an ailment with small doses of natural substances; Commonly available in Europe; Homeopathic marketers expect that to...

  • New drugs often not that new.  // Aging;1991, Issue 362, p44 

    Reports on a study by the Senate Special Committee on Aging that found the vast majority of new pharmaceuticals placed on the market have little or no advantage over the usually less expensive drug therapies.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics